Internal genitalia and uterine blood flow were assessed by ultrasound in 12 females 4.0-10.9 years after total body irradiation and allogeneic bone marrow transplantation for childhood leukaemia or lymphoma. Median age of the participants was 12.7 years (range 6.1-17.6) at bone marrow transplantation and 21.5 years (11.6-25.6) at the follow-up study. At follow-up all had entered puberty and 11/12 females had experienced the menarche. Eight females received sex steroid replacement therapy, three had spontaneous pubertal development and one woman experienced symptoms of estrogen deficiency. Median uterine and ovarian volumes were significantly reduced to ؊2.6 standard deviation scores (SDS) (؊6.3 to ؊0.6), P ‫؍‬ 0.002, and ؊2.6 SDS (؊4.8 to ؊0.5), P ‫؍‬ 0.002, respectively, compared with normal controls. Follicles were only detectable in two individuals. Uterine blood flow was impaired, as a systolic blood flow could be measured in 6/9 individuals, and a diastolic blood flow in 1/9 females. Our results indicate that the prescribed dosage of hormone replacement therapy, which was sufficient to induce bleeding and suppress other stigmata of premature menopause, was inadequate to generate normal uterine growth. In order to achieve uterine growth higher doses of hormone replacement therapy may be required. Our results confirm pelvic ultrasound as a reliable tool for investigation of internal female genitalia; however, in an infertility setting further tests are indicated. Keywords: BMT; TBI; childhood; uterus; ovary; uterine blood flow During the past two decades allogeneic bone marrow transplantation (BMT) has been used in the treatment of children with relapsed or very high risk leukaemia and lymphoma. Since many of these children become long-term survivors, the late effects of treatment are of major concern. Preparative regimens for BMT, high-dose chemotherapy alone or in combination with total body irradiation (TBI), may cause various endocrine abnormalities, 1-10 and ovarian failure resulting in life-long need for sex steroid replacement therapy (HRT) and infertility is common. Recovery of ovarian function occurs especially when preparative regimens do not include TBI, 5-11 and cases of pregnancies resulting in successful deliveries have been reported even when preparative regimens have included TBI.
During the past two decades allogeneic bone marrow transplantation (BMT) has been used in the treatment of children with relapsed or very high risk leukaemia and lymphoma. Since many of these children become long-term survivors, the late effects of treatment are of major concern. Preparative regimens for BMT, high-dose chemotherapy alone or in combination with total body irradiation (TBI), may cause various endocrine abnormalities, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] and ovarian failure
Correspondence: K Holm, Department of Growth and Reproduction, Section 5064, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark Received 26 March 1998; accepted 5 September 1998 resulting in life-long need for sex steroid replacement therapy (HRT) and infertility is common. Recovery of ovarian function occurs especially when preparative regimens do not include TBI, [5] [6] [7] [8] [9] [10] [11] and cases of pregnancies resulting in successful deliveries have been reported even when preparative regimens have included TBI. [12] [13] [14] [15] [16] [17] [18] [19] [20] The progress of assisted reproduction and the availability of oocyte donation has made pregnancy a possibility in women without ovarian function, provided there is normal function of the uterus. However, once pregnancy has been achieved, other problems may occur. In patients treated for solid tumours abdominal irradiation with 20-30 Gy have caused irreversible damage to uterine musculature and blood flow 21 and a high risk of adverse pregnancy outcome, eg low birth weight and increased perinatal mortality, have been reported. [22] [23] [24] [25] Recent reports have documented abortions, pre-term births and delivery of low birth weight infants after BMT and TBI. 13, 17, 18, 26 A reduction in uterine and ovarian size was found in five patients shortly after TBI and BMT. 9 It is important to note that the majority of women who achieved pregnancy were older than 18 years old at the time of TBI and BMT, and we lack information on the impact of TBI and BMT in childhood on internal genitalia. We have therefore studied internal female genitalia and uterine blood flow in young females treated with TBI and BMT for leukaemia or lymphoma in childhood and compared these findings to normal age-matched controls.
Material and methods

Subjects
Before 31 December 1990, 43 children from the Eastern part of Denmark were treated with allogeneic BMT at Rigshospitalet, Copenhagen for a malignant disease diagnosed before the age of 15. Twenty-nine of the 43 (survival 67%) were alive in January 1992 and had been off treatment for at least 1 year. Fourteen individuals had died because of relapse of the malignant disease (seven), interstitial pneumonia (three), graft-versus-host disease (GVHD) (three) and rejection (one). Twelve of the 14 females (86%) who were alive gave their informed consent to participate in the present study.
Eight participants had acute lymphoblastic leukaemia, two acute myeloblastic leukaemia, one T cell non-Hodgkin lymphoma and one chronic myelocytic leukaemia. Prior to referral for BMT, all patients had received multiagent chemotherapy for varying lengths of time, and 4/12 had had cranial irradiation (CI). None had had spinal irradiation. Three patients were in first complete remission and nine in second complete remission at BMT. Conditioning for BMT consisted of cyclophosphamide (CY) 60 mg/kg/day on 2 consecutive days and TBI given either unfractionated to a midline dose of 8.5-10 Gy (6cGy/min) (n ϭ 4), or to a total midline dose of 10.9-11.7 Gy in three fractions at 24 h interval (6-8.8 cGy/min) (n ϭ 8). Ten participants received marrow from an HLA-identical sibling, while the rest received marrow from other family donors. Three of the 12 participants developed acute GVHD of grade 2 or more, meaning a rash on more than 25% of the body surface, or GVHD of the liver and the gut. 27 None of the participants developed chronic GVHD.
Pubertal development and internal genitalia
At follow-up, breast and pubic hair development was staged according to Marshall and Tanner. 28 Uterine and ovarian volumes were assessed by transabdominal ultrasound scans using ALOKA SSD 680 with a curved linear 3.5 MHz transducer with colour and pulsed Doppler equipment, as previously described. 29 Ultrasound examinations were performed when the participant had a full bladder, by voluntary urine retention and oral administration of fluids. Uterine and ovarian volumes were calculated by measuring length, width and depth of the organs and by assuming the forms to be ellipsoid, using the formula based on an ellipsoid: 29 Age-specific standard deviation scores (SDS) ([observed value Ϫ predicted value]/standard deviation) were calculated for uterine and ovarian volumes. No significant difference was found between the right and left ovary, and ovarian size was expressed as the mean volume of both ovaries. Number and size of ovarian follicles were noted.
Blood flow velocities were measured on ramus arteriae uterinae ascendens. The insonation angle was corrected. Following parameters were recorded: (1) maximal flow velocity; (2) minimal flow velocity; (3) average flow velocity; and (4) pulsatility index (PI) was calculated electronically from the equation: PI ϭ (maximal systolic flow velocity Ϫ minimal diastolic flow velocity)/(average flow velocity). 30 PI is an expression of resistance to flow distal to the point of sampling.
Statistics
Nonparametric methods were used for statistical analyses including the Wilcoxon signed rank test for comparing uterine and ovarian volumes with 0. Values are expressed as median and range. Analyses were performed using a statistical software package (SPSS/PCϩ; SPSS).
Ethics
Written informed consent was obtained from every participant and/or parents, when the participant was less than 18 years old. The study was in accordance with the Helsinki II declaration and approved by the local ethical committee of Copenhagen, Denmark (approval No.V92.097).
Results
The median age of the 12 females was 11.2 years (range 2.5-15.0) at diagnosis, 12.7 years (6.1-17.6) at BMT and 21.5 years (11.6-25.6) at inclusion in the present study. A median of 8.2 years (4.0-10.9) had elapsed between BMT and follow-up. At follow-up all participants had entered puberty, and 11/12 had had the menarche. One girl had her menarche 14 months after participation in the study. The three youngest females (aged 11.6-15.5 years) had spontaneous pubertal development, while eight individuals received HRT to induce or maintain progress in puberty or to avoid symptoms of oestrogen deficiency. One woman aged 22 experienced symptoms of ovarian insufficiency and was placed on HRT. Table 1 gives age at BMT and at follow-up and preparative regimens, and Table 2 shows volume of ovaries and uterus, endometrial thickness, size of follicles, uterine blood flow, cycle day and sex steroid replacement at follow-up in the 12 females.
Median uterine volume was Ϫ2.6 standard deviation scores (SDS) (Ϫ6.3 to Ϫ0.6), P ϭ 0.002; and median ovarian volume was Ϫ2.6 SDS (Ϫ4.8 to Ϫ0.5), P ϭ 0.002. Figures 1 and 2 give uterine volume and ovarian volume related to age. Ovarian follicles could only be detected in 2/12 females (cases 7 and 12). Both females progressed through puberty without substitution therapy and experienced regular bleeds. The size of the follicles was between 6 and 17 mm.
In one girl (case 6) a large ovarian cyst of 5 ϫ 6 cm was found and removed surgically. Histological examination revealed a multilobulary mucinous benign cyst. No follicles were detected in the opposite ovary.
Assessments of uterine blood flow were carried out in nine participants. We found a systolic flow in 6/9 (67%) individuals, while a diastolic blood flow only could be detected in 1/9 (11%) of the participants. The pulsatility index could be calculated in 5/12 patients and the results are shown in Table 1 .
Discussion
As 7/12 (58%) of our participants were less than 13 years old at BMT the present study is the first to document the impact of BMT and TBI in childhood on internal female genitalia and uterine blood flow. We found a severe impact of TBI and BMT on the internal female genitalia causing reduced uterine and ovarian volumes despite HRT or spontaneous pubertal development. Our data indicate that the prescribed dose of HRT, which was sufficient to induce bleeding and suppress other stigmata of premature meno- BMT ϭ bone marrow transplantation. Ovarian volume is mean volume of both ovaries; except case 6, where the volume represents the right ovary, as the left was removed due to a 5 ϫ 6 cm large benign ovarian cyst, and cases 3 and 11, where the volume represents the left ovary, as the right could not be identified sufficiently. E ϭ Estradiol, N ϭ Norethisteron. pause, was inadequate to generate normal uterine growth. During normal puberty, uterine growth continues for several years after the menarche, 29 and it is likely that the growing uterus is more vulnerable to irradiation than the adult uterus. Our data indicate that incremental doses of HRT should be tried in order to effect normal uterine growth, and longitudinal ultrasound studies are useful tools in assessing the effects on the internal genitalia, including endometrial response. In an infertility setting further tests are indicated in screening for ovarian reserve. Baseline values of hormones and dynamic tests are useful, and day 3 serum inhibin-B levels and day 10 progesterone level seem predictive of ovarian reserve. 31 Decreased ovarian volume was reflected in lack of ovarian follicles, as ovarian follicles only could be detected in 2/12 (17%) of the patients (both had spontaneous puberty). In a recent study we found ovarian follicles in 99% of healthy females who had entered puberty. 29 Small ovaries have been associated with poor response to IVF. 32 We hypothesize that irradiation-induced impaired vascularization was a major cause of our findings, as a systolic blood flow only was detectable in 6/9 of the patients, while a diastolic blood flow only could be recorded in one female. In a recent study on flow velocity in the uterine artery during pubertal maturation in healthy females, we found a measurable diastolic flow in 35% of the prepubertal females and in 100% of adult women. 30 Critchley et al 21 also found absent Doppler flow signals in almost all uterine arteries in women who had received abdominal irradiation prepubertally. In contrast, uterine artery flow was present in women who experienced ovarian failure for other reasons. 21 Factors other than irradiation may be responsible for gonadal failure after BMT and TBI. Chatterjee et al 9 found evidence of gonadal insufficiency in 15 postmenarcheal females prior to BMT because of underlying illness and previous treatment, and BMT and TBI caused further ovarian damage. Surprisingly, they found similar hormonal changes in patients undergoing radiation-based regimens and those conditioned with high-dose chemotherapy alone. They also found intact anterior pituitary function, but this observation could be explained by the short follow-up period after BMT (3-4 months).
In our study, the three youngest females had spontaneous pubertal development, while 9/12 (75%) required HRT. In contrast, Sarafoglou et al 33 found that at least 50% of females undergoing BMT before puberty retained ovarian function adequate for puberty and regular menstruation. This discrepancy is probably explained by the fact that the participants in their study were younger at BMT and had hyperfractionated TBI. However, although some females experienced spontaneous pubertal development, they carry a substantial risk of early menopause. Byrne et al 34 found a significantly increased risk of menopause during the early 20s occurring after alkylating agents and irradiation below the diaphragm, especially when both treatments were given together.
Successful deliveries after BMT and TBI have been reported, [12] [13] [14] [15] 18, 35 but also spontaneous abortions, pre-term births and deliveries of low birth weight, and very low birth weight infants have been recognized. 13, 17, 18, 26 It is important to note that information on pregnancy outcome after BMT and TBI in childhood is sparse as the majority who experienced pregnancies were adults at TBI and BMT. However, Sanders et al 26 found that all pregnancies among five females who received TBI while prepubertal terminated with spontaneous abortion.
Rapid progress within the technologies of in vitro fertilisation and egg and embryo donation makes assisted fertility a theoretical option for patients with absent ovarian function after TBI and BMT. 36, 37 However, it still remains to be settled whether a uterus irradiated in childhood has the ability to grow as required during pregnancy. The impaired uterine blood flow demonstrated by us and others 21 warrants a sceptical attitude. Critchley et al 21 found the endometrium of women, who previously had had abdominal irradiation, unresponsive to physiological serum levels of oestradiol and progesterone in contrast to women who had absent ovarian function for other reasons.
In conclusion, uterine and ovarian volumes and number of ovarian follicles were reduced and uterine blood flow impaired after BMT and TBI despite spontaneous pubertal development or HRT. Higher doses of HRT should be tried in order to effect normal uterine growth and the impact on internal genitalia should be studied by longitudinal ultrasound investigations. When females become pregnant after BMT and TBI they should be considered as high-risk obstetric patients due to the risk of inadequate uterine growth during pregnancy.
